Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardlytics, Inc. - Common Stock (NQ:CDLX)

1.820 -0.070 (-3.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardlytics, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split. 
Via Benzinga
Cardlytics to Present at the 2022 Raymond James Technology Investors Conference
From Cardlytics, Inc.
Via GlobeNewswire
Here's Why Cardlytics Stock Sank to an All-Time Low on Wednesday
The business trends are worse than management expected. 
Via The Motley Fool
Cardlytics Sees Price Target Cut By 26% To Reflect Macro Headwinds
Via Benzinga
What 7 Analyst Ratings Have To Say About Cardlytics
Cardlytics (NASDAQ:CDLX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
12 Communication Services Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Looking Into Cardlytics's Recent Short Interest
Cardlytics's (NASDAQ:CDLX) short percent of float has risen 4.17% since its last report. The company recently reported that it has 4.53 million shares sold short, which is 19.72% of all regular shares... 
Via Benzinga
Looking Into Cardlytics's Return On Capital Employed
According to Benzinga Pro, during Q3, Cardlytics (NASDAQ:CDLX) earned $6.27 million, a 104.96% increase from the preceding quarter. Cardlytics's sales decreased to $72.71 million, a 3.58% change since... 
Via Benzinga
Cardlytics Announces Third Quarter 2022 Financial Results
From Cardlytics, Inc.
Via GlobeNewswire
Cardlytics Announces Timing of Its Third Quarter 2022 Financial Results Conference Call and Webcast
From Cardlytics, Inc.
Via GlobeNewswire
Where Cardlytics Stands With Analysts
Analysts have provided the following ratings for Cardlytics (NASDAQ:CDLX) within the last quarter: 
Via Benzinga
Recap: Cardlytics Q2 Earnings
Cardlytics (NASDAQ:CDLX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Where Cardlytics Stands With Analysts
Cardlytics (NASDAQ:CDLX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. 
Via Benzinga
10 Communication Services Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session
Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday. 
Via Benzinga
11 Communication Services Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. 
Via Benzinga
11 Communication Services Stocks Moving In Monday's Intraday Session
  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
  
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 100 companies reached new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's session, 61 companies made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 50 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
Upgrades 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.